ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 223 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,066 | -38.7% | 746 | -24.6% | 0.00% | – |
| Q2 2023 | $6,636 | -43.6% | 989 | -25.8% | 0.00% | – |
| Q1 2023 | $11,762 | +34.3% | 1,332 | +16.2% | 0.00% | – |
| Q4 2022 | $8,755 | +45.9% | 1,146 | +28.2% | 0.00% | – |
| Q3 2022 | $6,000 | -14.3% | 894 | +9.7% | 0.00% | – |
| Q2 2022 | $7,000 | 0.0% | 815 | +58.6% | 0.00% | – |
| Q1 2022 | $7,000 | -50.0% | 514 | +6.0% | 0.00% | -100.0% |
| Q4 2021 | $14,000 | -12.5% | 485 | +3.2% | 0.00% | 0.0% |
| Q3 2021 | $16,000 | -15.8% | 470 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $19,000 | 0.0% | 470 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $19,000 | – | 470 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
| Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
| Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
| Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
| TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
| Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
| Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
| Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
| Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |